A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: the ACT cluster-randomised trial. Issue 9968 (14th February 2015)
- Record Type:
- Journal Article
- Title:
- A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: the ACT cluster-randomised trial. Issue 9968 (14th February 2015)
- Main Title:
- A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: the ACT cluster-randomised trial
- Authors:
- Althabe, Fernando
Belizán, José M
McClure, Elizabeth M
Hemingway-Foday, Jennifer
Berrueta, Mabel
Mazzoni, Agustina
Ciganda, Alvaro
Goudar, Shivaprasad S
Kodkany, Bhalachandra S
Mahantshetti, Niranjana S
Dhaded, Sangappa M
Katageri, Geetanjali M
Metgud, Mrityunjay C
Joshi, Anjali M
Bellad, Mrutyunjaya B
Honnungar, Narayan V
Derman, Richard J
Saleem, Sarah
Pasha, Omrana
Ali, Sumera
Hasnain, Farid
Goldenberg, Robert L
Esamai, Fabian
Nyongesa, Paul
Ayunga, Silas
Liechty, Edward A
Garces, Ana L
Figueroa, Lester
Hambidge, K Michael
Krebs, Nancy F
Patel, Archana
Bhandarkar, Anjali
Waikar, Manjushri
Hibberd, Patricia L
Chomba, Elwyn
Carlo, Waldemar A
Mwiche, Angel
Chiwila, Melody
Manasyan, Albert
Pineda, Sayury
Meleth, Sreelatha
Thorsten, Vanessa
Stolka, Kristen
Wallace, Dennis D
Koso-Thomas, Marion
Jobe, Alan H
Buekens, Pierre M
… (more) - Abstract:
- Summary: Background: Antenatal corticosteroids for pregnant women at risk of preterm birth are among the most effective hospital-based interventions to reduce neonatal mortality. We aimed to assess the feasibility, effectiveness, and safety of a multifaceted intervention designed to increase the use of antenatal corticosteroids at all levels of health care in low-income and middle-income countries. Methods: In this 18-month, cluster-randomised trial, we randomly assigned (1:1) rural and semi-urban clusters within six countries (Argentina, Guatemala, India, Kenya, Pakistan, and Zambia) to standard care or a multifaceted intervention including components to improve identification of women at risk of preterm birth and to facilitate appropriate use of antenatal corticosteroids. The primary outcome was 28-day neonatal mortality among infants less than the 5th percentile for birthweight (a proxy for preterm birth) across the clusters. Use of antenatal corticosteroids and suspected maternal infection were additional main outcomes. This trial is registered withClinicalTrials.gov, numberNCT01084096 . Findings: The ACT trial took place between October, 2011, and March, 2014 (start dates varied by site). 51 intervention clusters with 47 394 livebirths (2520 [5%] less than 5th percentile for birthweight) and 50 control clusters with 50 743 livebirths (2258 [4%] less than 5th percentile) completed follow-up. 1052 (45%) of 2327 women in intervention clusters who deliveredSummary: Background: Antenatal corticosteroids for pregnant women at risk of preterm birth are among the most effective hospital-based interventions to reduce neonatal mortality. We aimed to assess the feasibility, effectiveness, and safety of a multifaceted intervention designed to increase the use of antenatal corticosteroids at all levels of health care in low-income and middle-income countries. Methods: In this 18-month, cluster-randomised trial, we randomly assigned (1:1) rural and semi-urban clusters within six countries (Argentina, Guatemala, India, Kenya, Pakistan, and Zambia) to standard care or a multifaceted intervention including components to improve identification of women at risk of preterm birth and to facilitate appropriate use of antenatal corticosteroids. The primary outcome was 28-day neonatal mortality among infants less than the 5th percentile for birthweight (a proxy for preterm birth) across the clusters. Use of antenatal corticosteroids and suspected maternal infection were additional main outcomes. This trial is registered withClinicalTrials.gov, numberNCT01084096 . Findings: The ACT trial took place between October, 2011, and March, 2014 (start dates varied by site). 51 intervention clusters with 47 394 livebirths (2520 [5%] less than 5th percentile for birthweight) and 50 control clusters with 50 743 livebirths (2258 [4%] less than 5th percentile) completed follow-up. 1052 (45%) of 2327 women in intervention clusters who delivered less-than-5th-percentile infants received antenatal corticosteroids, compared with 215 (10%) of 2062 in control clusters (p<0·0001). Among the less-than-5th-percentile infants, 28-day neonatal mortality was 225 per 1000 livebirths for the intervention group and 232 per 1000 livebirths for the control group (relative risk [RR] 0·96, 95% CI 0·87–1·06, p=0·65) and suspected maternal infection was reported in 236 (10%) of 2361 women in the intervention group and 133 (6%) of 2094 in the control group (odds ratio [OR] 1·67, 1·33–2·09, p<0·0001). Among the whole population, 28-day neonatal mortality was 27·4 per 1000 livebirths for the intervention group and 23·9 per 1000 livebirths for the control group (RR 1·12, 1·02–1·22, p=0·0127) and suspected maternal infection was reported in 1207 (3%) of 48 219 women in the intervention group and 867 (2%) of 51 523 in the control group (OR 1·45, 1·33–1·58, p<0·0001). Interpretation: Despite increased use of antenatal corticosteroids in low-birthweight infants in the intervention groups, neonatal mortality did not decrease in this group, and increased in the population overall. For every 1000 women exposed to this strategy, an excess of 3·5 neonatal deaths occurred, and the risk of maternal infection seems to have been increased. Funding: Eunice Kennedy Shriver National Institute of Child Health and Human Development. … (more)
- Is Part Of:
- Lancet. Volume 385:Issue 9968(2015)
- Journal:
- Lancet
- Issue:
- Volume 385:Issue 9968(2015)
- Issue Display:
- Volume 385, Issue 9968 (2015)
- Year:
- 2015
- Volume:
- 385
- Issue:
- 9968
- Issue Sort Value:
- 2015-0385-9968-0000
- Page Start:
- 629
- Page End:
- 639
- Publication Date:
- 2015-02-14
- Subjects:
- Medicine -- Periodicals
Medicine -- Periodicals
Medicine
Medicine
Electronic journals
Periodicals
610.5 - Journal URLs:
- http://www.thelancet.com/ ↗
http://www.sciencedirect.com/science/journal/01406736 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/S0140-6736(14)61651-2 ↗
- Languages:
- English
- ISSNs:
- 0140-6736
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5146.000000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 7921.xml